{
    "clinical_study": {
        "@rank": "55214", 
        "arm_group": [
            {
                "arm_group_label": "Aim 3: Contract", 
                "arm_group_type": "Experimental", 
                "description": "Half of patients screened in the pharmacy are selected to a contract group, which encourages patients to review the results of the screen, share the results with their PCP, and schedule and attend a follow-up appointment with an ophthalmologist if the results are abnormal."
            }, 
            {
                "arm_group_label": "Aim 3: Control", 
                "arm_group_type": "No Intervention", 
                "description": "No contract is signed for half of the patients screened in Aim 3."
            }
        ], 
        "brief_summary": {
            "textblock": "The goal of this project is to implement a Collaborative Translational Research Center (TRC)\n      Network Study which aims to assure optimal two-way communication between ophthalmologists\n      and their patients' primary care physicians (PCP). The Collaborative TRC Network Study will\n      have 2 objectives:\n\n        -  To design and develop common research protocols to develop a 4-year retrospective\n           database (2007-2010) that compiles electronic billing and medical chart information\n           that can be used to study individual-level, clinical-level and system-level factors\n           that impact access to and quality of vision care;\n\n        -  To evaluate adherence to dilated fundus exams (DFEs) follow-up as the primary\n           measureable quality indicator, and its relationship to the patients' demographics,\n           ethnicity, socioeconomic status (SES), severity of diabetic retinopathy (DR), other\n           ocular and medical co-morbidities, presence of HA1C, and primary care provider (PCP)\n           communication.\n\n      By enhancing communication and strengthening the clinical information exchanged between PCPs\n      and eye care professionals, this Collaborative TRC Network study will help to overcome\n      barriers to obtaining ongoing DFEs and reduce disparities in vision care utilization."
        }, 
        "brief_title": "Overcoming Barriers in Vision Care Utilization of African Americans With Diabetes", 
        "condition": [
            "Diabetic Retinopathy", 
            "Diabetes Mellitus", 
            "Dilated Eye Examinations"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetic Retinopathy", 
                "Retinal Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "Since its inception in October 2010 Collaborative Network Research Study at the Wills Eye\n      Institute has aimed:\n\n        1. to establish a retrospective analysis of existing ophthalmic data sets to assess and\n           evaluate system-level and individual-level factors that impact access to and quality of\n           vision care in patients with diabetes;\n\n        2. to implement telephone-based and educational interventions to improve DFE follow-up\n           adherence in African Americans with diabetes utilizing a prospective, cluster-based,\n           randomized cohort design;\n\n        3. to determine the feasibility and effectiveness of using a non-invasive, non-mydriatic\n           fundus camera (Nidek) in a community-based pharmacy setting to screen and detect\n           diabetic retinopathy and other ocular diseases among individuals with diabetes."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria for Aim 1:\n\n          1. Age \u2265 18 years\n\n          2. Type 2 diabetes mellitus\n\n          3. Had a dilated fundus exam (DFE) within the past four years (2007-2010).\n\n        Exclusion Criteria for Aim 1:\n\n        1) Pregnant women\n\n        Inclusion Criteria for Aim 2 and 3:\n\n          1. Age \u2265 18 years\n\n          2. Type 2 diabetes mellitus\n\n          3. Access to a telephone"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "3000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01744132", 
            "org_study_id": "U58DP002655"
        }, 
        "intervention": {
            "arm_group_label": "Aim 3: Contract", 
            "intervention_name": "Aim 3: Contract", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "eye care utilization", 
            "ophthalmology", 
            "educational intervention", 
            "public health screening"
        ], 
        "lastchanged_date": "November 26, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19107"
                }, 
                "name": "Jefferson Pharmacy"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "In Aim 1 and Aim 2 specifically the influence patients' ethnicity and severity of diabetic retinopathy will be examined with the rate of dilated fundus examine (DFE) follow-up adherence.\nIn Aim 3, the rate of DFE follow-up adherence will be examined for both patients in the contract and the no contract group.", 
            "measure": "All Aims: DFE follow-up adherence rate", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01744132"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Wills Eye", 
            "investigator_full_name": "Julia Haller", 
            "investigator_title": "Prinipal Investigator, Ophthalmologist-in-Chief", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "In Aim 3, the occurrence of diabetic retinopathy, glaucoma, cataracts, and other ocular diseases will be collected.", 
            "measure": "Aim 3: Rates of ocular disease", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "Wills Eye", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Centers for Disease Control and Prevention", 
                    "agency_class": "U.S. Fed"
                }, 
                {
                    "agency": "University of Alabama at Birmingham", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Miami", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Johns Hopkins University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Wills Eye", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}